Abstract
Personalized products, such as those based on genomic/metabolic profiling at the individual or population level Extension of health data services into biobanking and the view of biobanking from the perspective of healthcare information services) Online Cataloging services Artificial Intelligence implementation in biobanking COVID-related novel technology Direct to consumer/telemedicine opportunities for biobanks Cloud-based remote monitoring and automation Companion diagnostics Just-in-time biobanking models, their application and impact General new technologies (biobanking – software, preanalytics, cryopreservation) Journey to public market, how can biobanks support start-up and SMEs reaching their goals Novel biotechnology linked to population science/health